Stock 600267 ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
7.02 CNY -0.28% Intraday chart for Zhejiang Hisun Pharmaceutical Co., Ltd. -2.36% -25.00%
06-27 Hisun Pharmaceutical's Leukemia Drug Passes Chinese Drug Regulator's Consistency Evaluation MT
06-27 Hisun Pharmaceutical's Leukemia Drug Gets Marketing Approval MT

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 12,936 11,133 8,362 - -
Enterprise Value (EV) 1 12,936 15,209 8,362 8,362 8,362
P/E ratio 26.2 x -117 x 18 x 11.6 x 16.3 x
Yield - - 0.28% 0.28% 0.85%
Capitalization / Revenue - 1.07 x 0.82 x 0.66 x 0.76 x
EV / Revenue - 1.07 x 0.82 x 0.66 x 0.76 x
EV / EBITDA - 9.86 x 4.47 x 4.54 x 4.78 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 1.46 x 0.97 x 0.88 x 0.88 x
Nbr of stocks (in thousands) 1,173,876 1,189,385 1,177,697 - -
Reference price 2 11.02 9.360 7.020 7.020 7.020
Announcement Date 30/03/23 29/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 10,373 10,214 12,719 10,945
EBITDA 1 - 1,129 1,872 1,841 1,748
EBIT 1 - 430.3 896.9 1,088 914.1
Operating Margin - 4.15% 8.78% 8.55% 8.35%
Earnings before Tax (EBT) 1 - -82.87 397.5 859 440.3
Net income 1 489 -93.17 463.1 725.2 513
Net margin - -0.9% 4.53% 5.7% 4.69%
EPS 2 0.4200 -0.0800 0.3900 0.6050 0.4300
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share 2 - - 0.0200 0.0200 0.0600
Announcement Date 30/03/23 29/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales - - - - - - - - - -
EBITDA - - - - - - - - - -
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income 232.3 - - - - - - - - -
Net margin - - - - - - - - - -
EPS 1 0.1900 0.1800 0.0600 -0.4700 0.2100 0.1600 0.0900 -0.0600 0.1000 0.0100
Dividend per Share - - - - - - - - - -
Announcement Date 19/04/23 04/08/23 27/10/23 29/04/24 30/04/24 - - - - -
1CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - 4,076 - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - 3.612 x - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - -1.15% 5.57% 7.52% 5.58%
ROA (Net income/ Total Assets) - -0.51% 4.4% 4.9% -
Assets 1 - 18,194 10,526 14,801 -
Book Value Per Share 2 - 6.430 7.220 8.020 7.950
Cash Flow per Share 2 - 1.240 0.8500 1.740 -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 30/03/23 29/04/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Zhejiang Hisun Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
7.02 CNY
Average target price
7 CNY
Spread / Average Target
-0.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. Stock Zhejiang Hisun Pharmaceutical Co., Ltd.
-25.00% 1.14B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+42.60% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.68% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+1.84% 224B
NOVARTIS AG Stock Novartis AG
+13.27% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600267 Stock
  4. Financials Zhejiang Hisun Pharmaceutical Co., Ltd.